• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVO
Click for more information
0.00% $3.30

AVOCA RESOURCES LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AVO
Ann: mFund - Monthly Redemption Report - AVO01 		07/03/19 0 116
07/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  116 
AVO
Ann: mFund - Fund Termination - AVO01 		26/02/19 0 73
26/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  73 
AVO
Ann: mFund - Fund Profile - AVO01 		26/02/19 0 60
26/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  60 
AVO
Ann: mFund - Monthly Redemption Report - AVO01 		06/02/19 0 70
06/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  70 
AVO
Ann: mFund - Monthly Redemption Report - AVO01 		09/01/19 0 90
09/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  90 
AVO
Ann: mFund - Distribution - AVO01 		09/01/19 0 93
09/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  93 
AVO
Ann: mFund - Monthly Redemption Report - AVO01 		06/12/18 0 148
06/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 
AVO
Ann: mFund - Monthly Redemption Report - AVO01 		07/11/18 0 123
07/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  123 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.